226 related articles for article (PubMed ID: 28380402)
1. The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.
Boddu P; Falchi L; Hosing C; Newberry K; Bose P; Verstovsek S
Leuk Res; 2017 Jul; 58():14-22. PubMed ID: 28380402
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic thrombocytapheresis for extreme thrombocytosis after chemotherapy in essential thrombocytosis.
Almeida-Dias R; Garrote M; Cid J; Mustieles MJ; Alba C; Lozano M
J Clin Apher; 2019 Aug; 34(4):503-506. PubMed ID: 30624802
[TBL] [Abstract][Full Text] [Related]
3. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.
Baron BW; Mick R; Baron JM
Cancer; 1993 Aug; 72(4):1209-18. PubMed ID: 8339212
[TBL] [Abstract][Full Text] [Related]
4. Managing uncontrolled postsplenectomy reactive thrombocytosis in idiopathic thrombocytopenic purpura: role of thrombocytapheresis.
Das SS; Bhattacharya S; Sen S
Transfus Apher Sci; 2013 Oct; 49(2):171-3. PubMed ID: 23871583
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic thrombocytapheresis: a review of 132 patients.
Adami R
Int J Artif Organs; 1993 Dec; 16 Suppl 5():183-4. PubMed ID: 8013984
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic thrombocytapheresis in myeloproliferative neoplasms: A single-institution experience.
Nguyen TH; Bach KQ; Vu HQ; Nguyen NQ; Duong TD; Wheeler J
J Clin Apher; 2021 Feb; 36(1):101-108. PubMed ID: 33037852
[TBL] [Abstract][Full Text] [Related]
8. The role of blood component removal in essential and reactive thrombocytosis.
Greist A
Ther Apher; 2002 Feb; 6(1):36-44. PubMed ID: 11886575
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.
Debureaux PE; Brignier A; Soret-Dulphy J; Réa D; Michonneau D; Peffault de Latour R; Sicre de Fontbrune F; Pagliuca S; Parquet N; Prata HP; Marouf A; Xhaard A; Kiladjian JJ; Socié G; Robin M
Ann Hematol; 2020 Apr; 99(4):897-898. PubMed ID: 32030449
[No Abstract] [Full Text] [Related]
10. Primary thrombocythemia: a current perspective.
Mughal TI
Stem Cells; 1995 Jul; 13(4):355-9. PubMed ID: 7549894
[TBL] [Abstract][Full Text] [Related]
11. Improvement of platelet function following plateletpheresis in patients with myeloproliferative diseases.
Orlin JB; Berkman EM
Transfusion; 1980; 20(5):540-5. PubMed ID: 7423594
[TBL] [Abstract][Full Text] [Related]
12. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
Steurer M; Gastl G; Jedrzejczak WW; Pytlik R; Lin W; Schlögl E; Gisslinger H
Cancer; 2004 Nov; 101(10):2239-46. PubMed ID: 15476273
[TBL] [Abstract][Full Text] [Related]
13. Plateletpheresis: Nonoperative Management of Symptomatic Carotid Thrombosis in a Patient with Reactive Thrombocytosis.
Martínez RC; Quaynor S; Alkhalifah M; Goldenberg FD
World Neurosurg; 2018 Jun; 114():126-129. PubMed ID: 29555611
[TBL] [Abstract][Full Text] [Related]
14. The effect of thrombocytapheresis on hemogram and biochemistry parameters in patients with essential thrombocytemia.
Kaya A; Kuku İ; Erkurt MA; Kaya E; Berber İ; Biçim S; Hidayet E; Cırık S; Arslan S; Yagin FH; Sarıcı A
Transfus Clin Biol; 2023 Nov; 30(4):421-425. PubMed ID: 37558046
[TBL] [Abstract][Full Text] [Related]
15. Control of thrombocytosis by plateletpheresis using a cell separator.
Beard ME; Blacklock HA; Varcoe AR
N Z Med J; 1980 Feb; 91(654):136-8. PubMed ID: 6929973
[TBL] [Abstract][Full Text] [Related]
16. [Essential thrombocythemia as a cause of headache in young woman].
Bieniaszewska M; Balon J; Hellmann A
Pol Merkur Lekarski; 2000 Jul; 8(49):479-80. PubMed ID: 11070720
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic plateletpheresis in thombocythemia.
Panlilio AL; Reiss RF
Transfusion; 1979; 19(2):147-52. PubMed ID: 432925
[TBL] [Abstract][Full Text] [Related]
18. Extreme thrombocytosis and cardiovascular surgery: risks and management.
Natelson EA
Tex Heart Inst J; 2012; 39(6):792-8. PubMed ID: 23304015
[TBL] [Abstract][Full Text] [Related]
19. Bleeding and thrombosis in the myeloproliferative disorders.
Schafer AI
Blood; 1984 Jul; 64(1):1-12. PubMed ID: 6375757
[TBL] [Abstract][Full Text] [Related]
20. Plateletpheresis in the management of thrombocytosis.
Taft EG; Babcock RB; Scharfman WB; Tartaglia AP
Blood; 1977 Nov; 50(5):927-33. PubMed ID: 907841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
